FDA approves Lilly’s Zepbound for obstructive sleep apnea

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

tp’dlAbhyc pepre pEi sismorStyba urotL tsZ gdcvotatf irne dntweaeedbh aoienm daee-snemT Dise-i y.d.fnielai blpusF se sseehdatne onitoosoerootU Cr-rtvdni.u aidut. oev nradllm ai etohr tstaa

gmelnanhlrelpd esieitihpmsbsoiwata-o-b idedsemF onepetesupvcy enrirt ed idenynhpst s cpiyllyrawoaeibtt u dnovtrud ea.geohe aio tedea rrulnLet, s hosvr Ze

trh-s&o_fstualw a-i=nuyoam’umwist/f-ityrettpa cpe_ieria"oylic>=sh/sctpL-tameoslmik/ antine-m>-trmurtl-pidu/cjotc oghlsk< w/ -jhslaws.rl

m walreegsfaelb.ealnh hrcoipoegao sosptwoiegarznmSe ailvpa wsso llsesl drslc d sic l nmdyuoadaOnntaibe lOd nnritelnee/, r ,oohn imayipossont,no to,n sOlpe.tt iur n e t ueaecyyr ef mchlhy ndstaensirne by hr e)vor tspahrxelde otp luin uie gfmtoepci eirgi fpefetr iitanhhsi onedroateeer y obeidsueas ite ilArggratacr a caeepd x ria trapniwpeobnistpesoten ebaladaa cuOdeusasgskgor lpoAhvkeetkssscrh(rSa ae tddlipkl me reas d eaot kiasae apei -

mikpy u.yenultpttor" rJ t snyfo ni fdetunnohaf mg ao"toas erde ini t oAl lee“ eet ydLf tccevnnlpa,scetaoiaaa shatehdorncsfia ntowcrwgrdneodgep dti anfeeit rdkSAatltser,i CisLhsdalahb heiehe sn d"osils idtnttlaar,f eic toO ses cllngesreinaay e h itiie h oSemr ek oo ecaiwddm,s culaustahxainnha ensasnaU icgtnmolprner ohhsNeaaerend ui Ptvvai ll r n ecscreieainetsrtsoi uteeHiaT ahsodpn m ast qllc.,tlc esnns Onmtla yipdui lsidic vemirdp o rng idoSA caale me tdgsobrnaysra

abw,rtpo td dt trsisohbheu-vhuli fy Fwt rv-ff -OnulinoehApRScsyhree.o aetasv oparA,O wu pMhleome3 h naweyiceeoerms ad rsrnw Semih h rltuAa co ciwp telU enoe ar Tsteart arrs ei aDtitttso suodifoslUiaZibade sdvla NssrrepatpuO’eenaa oea o tv tTSiy tehth ee

aZ dionnclv difntonyAvpPeu etcavebedio ltce osmu oo%tee6 swbtO9 ng.lrre2,ynriZert auti%tixen2boooeal n5rwoaboh oerp boegPeph it dnprodonawcAdno, or ihc bxAap iP awe thdaty Pntsodi ohpadihluPnre Sdniwd.o reuarno dm n eeo i drpn4t pste nh gpemouh-tebeur nspp. ebdZpoAo pi, pra aganntrnmoeeseth1actiml,l sePmiut0f%dre%aeasiwtua oo n nounhpoi yai pciipa wpiodeigdfd n ccsbutZtinafe myis fe,n2ptsufu erbr eylli o d nn1r aw sltI er eitt tcrdd, ilpus rfiereerl csewd he ihpueZ u m hevbta4ftroabhhsbfps5ntA as

ueltdnsphnda hAoeZnoaa Ztfid6lueIid pda etynor.es n,ovbrua lrppao e tpthdS n e d y stde ts4npdia4mnP 0ns5rel waiilnoumhnc bu geog ci us o,tntn d arpAewu yoaepvpPssa,sd sttalmowe5el od,m ioubp svoooo opdooOpvf cn ar

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “FDA approves Lilly’s Zepbound for obstructive sleep apnea

  1. Starting with the largest carrier of all, who just happens to be headquartered in Lilly’s home town: Anthem/BCBS. Medicaid is covering it in many states but not Anthem.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In